Funder: Breakthrough T1D
Due Dates: Rolling (LOIs accepted year-round by invitation or RFA); see program page for current RFA deadlines
Funding Amounts: No fixed upper limit; funding amount as approved, typically commensurate with project scope. Requires 1:1 company matching funds.
Summary: Supports for-profit companies developing innovative, commercially promising type 1 diabetes research aligned with Breakthrough T1D’s strategic priorities.
Key Information: LOI required prior to full proposal; indirect costs not permitted; company matching funds required.